2025-01-01
2025-03-31
0000059478
country:US
lly:NeuroscienceMember
2024-01-01
2024-03-31
0000059478
us-gaap:NonUsMember
lly:NeuroscienceMember
2024-01-01
2024-03-31
0000059478
lly:NeuroscienceMember
2024-01-01
2024-03-31
0000059478
country:US
lly:OtherProductTotalMember
2025-01-01
2025-03-31
0000059478
us-gaap:NonUsMember
lly:OtherProductTotalMember
2025-01-01
2025-03-31
0000059478
lly:OtherProductTotalMember
2025-01-01
2025-03-31
0000059478
country:US
lly:OtherProductTotalMember
2024-01-01
2024-03-31
0000059478
us-gaap:NonUsMember
lly:OtherProductTotalMember
2024-01-01
2024-03-31
0000059478
lly:OtherProductTotalMember
2024-01-01
2024-03-31
0000059478
country:US
2025-01-01
2025-03-31
0000059478
us-gaap:NonUsMember
2025-01-01
2025-03-31
0000059478
country:US
2024-01-01
2024-03-31
0000059478
us-gaap:NonUsMember
2024-01-01
2024-03-31
0000059478
srt:EuropeMember
2025-01-01
2025-03-31
0000059478
srt:EuropeMember
2024-01-01
2024-03-31
0000059478
country:CN
2025-01-01
2025-03-31
0000059478
country:CN
2024-01-01
2024-03-31
0000059478
country:JP
2025-01-01
2025-03-31
0000059478
country:JP
2024-01-01
2024-03-31
0000059478
lly:RestOfWorldMember
2025-01-01
2025-03-31
0000059478
lly:RestOfWorldMember
2024-01-01
2024-03-31
0000059478
lly:JardianceMember
lly:OneTimePaymentMember
2025-01-01
2025-03-31
0000059478
lly:BoehringerIngelheimMember
lly:MilestonePaymentsSalesBasedMember
2025-03-31
0000059478
lly:RocheMember
lly:EbglyssMember
lly:MilestonePaymentsSalesBasedMember
2025-03-31
0000059478
lly:EbglyssMember
lly:MilestonePaymentsSalesBasedMember
2025-03-31
0000059478
lly:ChugaiMember
lly:OrforglipronMember
lly:MilestonePaymentsDevelopmentAndRegulatoryMember
2025-03-31
0000059478
lly:ChugaiMember
lly:OrforglipronMember
lly:MilestonePaymentsSalesBasedMember
2025-03-31
0000059478
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2025-03-31
0000059478
us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember
2025-03-31
0000059478
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2025-03-31
0000059478
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2025-03-31
0000059478
us-gaap:FairValueInputsLevel3Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2025-03-31
0000059478
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2025-03-31
0000059478
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2025-03-31
0000059478
us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2025-03-31
0000059478
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2025-03-31
0000059478
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2025-03-31
0000059478
us-gaap:FairValueInputsLevel3Member
us-